The Johns Hopkins University researcher’s work helped solidify the link between human papillomavirus and cervical cancer, leading to the approval of the HPV vaccine in 2006.
The Scientist Creative Services Team | Aug 20, 2020
Joseph Powell will discuss how heterogeneous subpopulations of HPV+ head and neck cancer cells drive unique disease states, cell-cell interactions, and microenvironment dynamics, and have implications for cancer behavior, metastasis, and response to treatment.
The editor in chief of Vaccine has “temporarily removed” a study, published on the journal’s website in January, which suggested the aluminum adjuvant in an HPV vaccine caused behavioral changes in mice.
In contrast to yesterday’s news about the success of an HPV vaccine program in Australia, an Indian trial of the vaccine is stoking unfounded fear among the public and exposing some questionable ethical standards.
